## RO-Crate Summary

ROCrate ID
ark:59853/rocrate-b2ai-aireadi-release-3-0-0
DOI
https://doi.org/10.60775/fairhub.3
Release Date
11/17/25
Description
The Artificial Intelligence Ready and Exploratory Atlas for Diabetes Insights (AI-READI) project seeks to create a flagship ethically-sourced dataset to enable future generations of artificial intelligence/machine learning (AI/ML) research to provide critical insights into type 2 diabetes mellitus (T2DM), including salutogenic pathways to return to health. The ability to understand and affect the course of complex, multi-organ diseases such as T2DM has been limited by a lack of well-designed, high quality, large, and inclusive multimodal datasets. The AI-READI team of investigators will aim to collect a cross-sectional dataset of 4,000 people and longitudinal data from 10% of the study cohort across the US. The study cohort will be balanced for self-reported race/ethnicity, gender, and diabetes disease stage. Data collection will be specifically designed to permit downstream pseudo-time manifold analysis, an approach used to predict disease trajectories by collecting and learning from complex, multimodal data from participants with differing disease severity (normal to insulin-dependent T2DM). The long-term objective for this project is to develop a foundational dataset in T2DM, agnostic to existing classification criteria or biases, which can be used to reconstruct a temporal atlas of T2DM development and reversal towards health (i.e., salutogenesis). Data will be optimized for downstream AI/ML research and made publicly available This dataset contains data from 2280 participants that was collected between July 19, 2023 and May 01, 2025. Data from multiple modalities are included. A full list is provided in the Data Standards section below. The data in this dataset contain no protected health information (PHI). Information related to the sex and race/ethnicity of the participants as well as medication used has also been removed. The dataset contains 356,343 files and is around 3.82 TB in size. A detailed description of the dataset is available in the AI-READI documentation for v3.0.0 of the dataset at docs.aireadi.org.
Authors
AI-READI Consortium
Publisher
AI-READi Consortium
Principal Investigator
Aaron Lee, Department of Ophthalmology, University of Washington
License
https://doi.org/10.5281/zenodo.17555036
Confidentiality Level
HL7:2N (normal)
Keywords
diabetes mellitus, Machine Learning, Artificial Intelligence, Electrocardiography, Continuous Glucose Monitoring, Retinal Imaging, Eye Exam
Citation
https://docs.aireadi.org
Related Publications

- AI-READI Consortium. (2024). "AI-READI: rethinking data collection, preparation and sharing for propelling AI-based discoveries in diabetes research and beyond." Nature metabolism. https://doi.org/10.1038/s42255-024-01165-x
- AI-READI Consortium. (2025). Flagship Dataset of Type 2 Diabetes from the AI-READI Project (3.0.0) [Data set]. FAIRhub. https://doi.org/10.60775/fairhub.3

No datasets found in this RO-Crate.

No software found in this RO-Crate.

No computations found in this RO-Crate.

No samples found in this RO-Crate.

No experiments found in this RO-Crate.

No instruments found in this RO-Crate.

No schemas found in this RO-Crate.

No other found in this RO-Crate.